Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Cancer. 2016 Oct 3;123(3):459–467. doi: 10.1002/cncr.30376

Table 3.

Multivariate analysis for the risk of relapse or death among patient with adult Ph- ALL.

Variable Hazard ratio (95% CI) P
Risk of relapse or death

Age 1.01 (1.01-1.02) 0.03
WBC 1.24 (1.04-1.38) 0.01
Platelet count 1.20 (1.04-1.38) 0.01
Performance status ≥ 2 1.81 (1.12-2.92) 0.02
Ho-Tr 2.65 (1.28-5.52) 0.01
Complex karyotype 2.58 (1.39-4.80) < 0.01
MRD positive 1.82 (1.24-2.68) < 0.01
Risk of death

Age 1.02 (1.01-1.03) < 0.01
WBC 1.17 (1.01-1.36) 0.04
Performance status ≥ 2 1.72 (1.03-2.86) 0.04
Ho-Tr 3.15 (1.40-7.09) 0.01
Complex karyotype 2.42 (1.26-4.66) 0.01
MRD positive 1.93 (1.27-2.92) < 0.01

Ho-Tr, Low hpodiploidy/near-triploidy. WBC and platelet count were analyzed as log (WBC) and log (platelet). Decreased performance status was defined as ECOG PS ≥ 2. All cytogenetic subgroups were compared to the diploid subgroup.